Acquired by Siemens Healthineers
VAR - Varian Medical Systems, Inc.
NYSE
->
Healthcare
->
Medical Instruments & Supplies
United States
Type: Equity
VAR price evolution
VAR
| (in millions $) | 31 Dec 2020 | 30 Sep 2020 | 30 Jun 2020 | 31 Mar 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $773.3 | $766.1 | $769.2 | $667.8 |
| Short term investments | ||||
| Net receivables | $1029.3 | $1066.1 | $987.4 | $1004.8 |
| Inventory | $571.7 | $516.3 | $600.4 | $604 |
| Total current assets | $2641.3 | $2603.3 | $2631.7 | $2500.9 |
| Long term investments | ||||
| Property, plant & equipment | $466 | $465.9 | $469.9 | $465.7 |
| Goodwill & intangible assets | $892.7 | $895.2 | $873.1 | $896.3 |
| Total noncurrent assets | $1884.8 | $1858.9 | $1822.7 | $1843 |
| Total investments | ||||
| Total assets | $4526.1 | $4462.2 | $4454.4 | $4343.9 |
| Current liabilities | ||||
| Accounts payable | $206.5 | $194.9 | $164.5 | $198.4 |
| Deferred revenue | $845.7 | $782.2 | $778.4 | $798.1 |
| Short long term debt | $210 | $355 | $580 | $520 |
| Total current liabilities | $1744.9 | $1854.5 | $1991.4 | $1949.7 |
| Long term debt | $101.7 | $101.1 | $102.6 | $100.4 |
| Total noncurrent liabilities | $533.4 | $522.9 | $519.9 | $523.5 |
| Total debt | $311.7 | $456.1 | $682.6 | $620.4 |
| Total liabilities | $2278.3 | $2377.4 | $2511.3 | $2473.2 |
| Shareholders' equity | ||||
| Retained earnings | $1225.6 | $1133 | $1054.9 | $993.7 |
| Other shareholder equity | -$76.8 | -$85.7 | -$113.5 | -$101.8 |
| Total shareholder equity | $2238.3 | $2075.5 | $1933.5 | $1860.8 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $766.1 | $531.4 | $504.8 | $716.2 |
| Short term investments | ||||
| Net receivables | $1066.1 | $1106.3 | $1009.9 | $823.5 |
| Inventory | $516.3 | $551.5 | $438.1 | $439.7 |
| Total current assets | $2603.3 | $2395.4 | $2188.4 | $2190.3 |
| Long term investments | ||||
| Property, plant & equipment | $465.9 | $311.5 | $274.6 | $255.3 |
| Goodwill & intangible assets | $895.2 | $912.9 | $394.7 | $294.2 |
| Total noncurrent assets | $1858.9 | $1706.3 | $1064.3 | $989.1 |
| Total investments | ||||
| Total assets | $4462.2 | $4101.7 | $3252.7 | $3179.4 |
| Current liabilities | ||||
| Accounts payable | $194.9 | $248.5 | $190.3 | $162.3 |
| Deferred revenue | $782.2 | $766 | $729.7 | $640.6 |
| Short long term debt | $355 | $410 | $350 | |
| Total current liabilities | $1854.5 | $1884 | $1339.7 | $1550.1 |
| Long term debt | $101.1 | |||
| Total noncurrent liabilities | $522.9 | $440.1 | $324.3 | $130 |
| Total debt | $456.1 | $410 | $350 | |
| Total liabilities | $2377.4 | $2324.1 | $1664 | $1680.1 |
| Shareholders' equity | ||||
| Retained earnings | $1133 | $934 | $780.4 | $756 |
| Other shareholder equity | -$85.7 | -$102.1 | -$65.3 | -$68.8 |
| Total shareholder equity | $2075.5 | $1768.3 | $1584.4 | $1495 |
| (in millions $) | 31 Dec 2020 | 30 Sep 2020 | 30 Jun 2020 | 31 Mar 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $778.8 | $850.5 | $694.3 | $794.5 |
| Cost of revenue | $419.8 | $475.8 | $395.8 | $457.3 |
| Gross Profit | $359 | $374.7 | $298.5 | $337.2 |
| Operating activities | ||||
| Research & development | $72.2 | $77.2 | $65.3 | $71 |
| Selling, general & administrative | $161.9 | $174.5 | $145 | $175.3 |
| Total operating expenses | $241.8 | $276.3 | $238.6 | $282.3 |
| Operating income | $117.2 | $98.4 | $59.9 | $54.9 |
| Income from continuing operations | ||||
| EBIT | $125.4 | $110.2 | $88 | $57.2 |
| Income tax expense | $27.6 | $31.5 | $23.9 | $9.7 |
| Interest expense | $1.3 | $2.1 | $2.9 | $4.3 |
| Net income | ||||
| Net income | $96.5 | $76.6 | $61.2 | $43.2 |
| Income (for common shares) | $96.5 | $76.6 | $61.2 | $43.2 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3168.2 | $3225.1 | $2919.1 | $2668.2 |
| Cost of revenue | $1791 | $1854.8 | $1645.5 | $1512.6 |
| Gross Profit | $1377.2 | $1370.3 | $1273.6 | $1155.6 |
| Operating activities | ||||
| Research & development | $280.6 | $247.6 | $233.9 | $210 |
| Selling, general & administrative | $671.8 | $623.1 | $539.3 | $552.3 |
| Total operating expenses | $1054 | $984.1 | $832 | $813.7 |
| Operating income | $323.2 | $386.2 | $441.6 | $341.9 |
| Income from continuing operations | ||||
| EBIT | $372.1 | $429.3 | $458.5 | $348 |
| Income tax expense | $88.9 | $128.6 | $301.8 | $87.7 |
| Interest expense | $14 | $8.8 | $6.8 | $10.7 |
| Net income | ||||
| Net income | $269.2 | $291.9 | $149.9 | $249.6 |
| Income (for common shares) | $269.2 | $291.9 | $149.9 | $249.6 |
| (in millions $) | 31 Dec 2020 | 30 Sep 2020 | 30 Jun 2020 | 31 Mar 2020 |
|---|---|---|---|---|
| Net income | $96.5 | $76.6 | $61.2 | $43.2 |
| Operating activities | ||||
| Depreciation | $25.8 | $25.3 | $24 | $24.4 |
| Business acquisitions & disposals | -$0.5 | -$27.8 | -$6.7 | |
| Stock-based compensation | $16.7 | $13.3 | $4.4 | $11.3 |
| Total cash flows from operations | $141.4 | $266.6 | $83 | $21.9 |
| Investing activities | ||||
| Capital expenditures | -$16.8 | -$29.3 | -$18 | -$14.4 |
| Investments | -$10.3 | -$5 | -$21.3 | |
| Total cash flows from investing | -$27.6 | -$63 | -$41.1 | -$21.1 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $52.4 | $24.6 | $19.3 | -$30 |
| Net borrowings | -$145 | -$225 | $60 | -$22 |
| Total cash flows from financing | -$100.2 | -$204.4 | $67.8 | -$59.9 |
| Effect of exchange rate | -$6.3 | -$3.9 | -$8.2 | $5.9 |
| Change in cash and equivalents | $7.3 | -$4.7 | $101.5 | -$53.2 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Net income | $269.2 | $291.9 | $149.9 | $249.6 |
| Operating activities | ||||
| Depreciation | $98.9 | $93 | $72.7 | $76.9 |
| Business acquisitions & disposals | -$36.2 | -$577.8 | -$130.5 | -$11.4 |
| Stock-based compensation | $43.9 | $47.9 | $45.9 | $40.9 |
| Total cash flows from operations | $484.1 | $371.8 | $454.9 | $399.1 |
| Investing activities | ||||
| Capital expenditures | -$84.3 | -$58 | -$47.7 | -$59.1 |
| Investments | -$17.1 | $5.6 | $4.4 | -$56.1 |
| Total cash flows from investing | -$140.3 | -$631.7 | -$184 | -$130.1 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$10.2 | -$103.3 | -$121.2 | -$222.4 |
| Net borrowings | -$55 | $393.2 | -$350 | -$114.5 |
| Total cash flows from financing | -$93.1 | $279.2 | -$487 | -$392.4 |
| Effect of exchange rate | -$9 | $8.4 | $4.7 | -$3.9 |
| Change in cash and equivalents | $241.7 | $27.7 | -$211.4 | -$127.3 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 91.84M |
| Revenue | $3.12B |
|---|---|
| EBITDA | $480.30M |
| EBIT | $380.80M |
| Net Income | $277.50M |
| Revenue Q/Q | -6.04% |
| Revenue Y/Y | -5.88% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 25.21 |
| Cash/Share | 8.42 |
| EPS | $3.02 |
|---|---|
| ROA | 6.24% |
| ROE | 13.69% |
| Debt/Equity | 1.15 |
|---|---|
| Net debt/EBITDA | 3.13 |
| Current ratio | 1.51 |
| Quick ratio | 1.19 |